Direxion Daily Pharmaceutical & Medical Bull 3X ETF
PILL
5 hedge funds and large institutions have $493K invested in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
388% more capital invested
Capital invested by funds: $101K → $493K (+$392K)
150% more funds holding
Funds holding: 2 → 5 (+3)
3.96% more ownership
Funds ownership: 1.04% → 4.99% (+4%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$388K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$59.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$30.6K |
PILL Hedge Fund Activity: Q4 2022 in Review
5 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) for Q4 2022, worth a combined $493K — up 388% from $101K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PILL positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $388K. The largest seller was UBS Group, cutting an estimated $30.6K.
- 5 institutional investors held Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) as of Q4 2022, up from 2 in Q3 2022.
- Funds reported $493K of Direxion Daily Pharmaceutical & Medical Bull 3X ETF stock for Q4 2022, up 388% quarter-over-quarter.
- 3 funds opened new Direxion Daily Pharmaceutical & Medical Bull 3X ETF positions in Q4 2022 and 0 closed out, a net change of +3 holders.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF buyer in Q4 2022 was Susquehanna International Group, an estimated $388K added.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF seller in Q4 2022 was UBS Group, an estimated $30.6K sold.
Based on aggregated 13F filings for Q4 2022.